Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in increased expression of OLFM4 mRNA | increases expression | 21048224
|
C006780 |
bisphenol A |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of OLFM4 mRNA] | decreases reaction|increases expression | 19228888
|
D003035 |
Cobalt |
[tungsten carbide binds to Cobalt] which results in decreased expression of OLFM4 mRNA | affects binding|decreases expression | 20105288
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of OLFM4 mRNA | increases expression | 15679045
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of OLFM4 protein | increases expression | 15679045
|
D004958 |
Estradiol |
EGF protein promotes the reaction [Estradiol results in increased expression of OLFM4 mRNA] | increases expression|increases reaction | 21048224
|
D004958 |
Estradiol |
Estradiol results in increased expression of OLFM4 mRNA | increases expression | 21048224
|
D004958 |
Estradiol |
ICI 164384 inhibits the reaction [EGF protein promotes the reaction [Estradiol results in increased expression of OLFM4 mRNA]] | decreases reaction|increases expression|increases reaction | 21048224
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of OLFM4 mRNA | increases expression | 17557909
|
C051781 |
ICI 164384 |
ICI 164384 inhibits the reaction [EGF protein promotes the reaction [Estradiol results in increased expression of OLFM4 mRNA]] | decreases reaction|increases expression|increases reaction | 21048224
|
D014284 |
Triiodothyronine |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of OLFM4 mRNA] | decreases reaction|increases expression | 19228888
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of OLFM4 mRNA | increases expression | 19228888
|
C002802 |
tungsten carbide |
[tungsten carbide binds to Cobalt] which results in decreased expression of OLFM4 mRNA | affects binding|decreases expression | 20105288
|
C002802 |
tungsten carbide |
tungsten carbide results in decreased expression of OLFM4 mRNA | decreases expression | 20105288
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.26 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.37 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.37 | 14692618 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.72 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.77 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.77 | 15885639 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.07 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.12 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cobalt |
2.12 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.12 | 18497071 17289903 19861407 16675129 17261762 12948864 14630087 17018787 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.75 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.78 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.27 | 17123778 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.91 | 18566989 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.02 | 17681005 17110522 16919318 15861022 16105132 11677210 17333356 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.52 | 15824018 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
2.29 | 17728286 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.66 | 12438553 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.59 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.93 | 7237001 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.70 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
3.60 | 19703484 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.42 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
8.21 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.21 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
marker/mechanism |
|
| 21048224 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
3.02 | 15345470 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.13 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.35 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.07 | 17088409 |
MESH:D006973 |
Hypertension |
|
Cobalt |
6.21 | 17039479 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
6.21 | 17042910 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.07 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.68 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.62 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
2.97 | 8960868 11099482 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.86 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.86 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.69 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.15 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
2.69 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.69 | 14659978 14716833 |
MESH:D008173 |
Lung Diseases, Obstructive |
|
Cobalt |
6.12 | 6434250 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
2.27 | 15824018 11195469 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.68 | 16891317 11408345 11807958 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.80 | 19453300 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.65 | 16118317 15867202 15744524 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.65 | 9809623 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.44 | 16810080 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.02 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.55 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.55 | 11399458 16427766 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.27 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.27 | 19401270 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.91 | 11578682 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.65 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.24 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
11.25 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
11.25 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.22 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.22 | 16740699 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.60 | 15861022 16919318 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.07 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cobalt |
4.06 | 6434250 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
4.24 | 11700416 18379247 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.26 | 16709447 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.60 | 15472012 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.69 | 15138204 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.27 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.84 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.33 | 15669648 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.00 | 19048282 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.33 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.54 | 14692618 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
5.13 | 1336536 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.75 | 14671159 15869587 |